{"id":"NCT02149121","sponsor":"Celltrion","briefTitle":"PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis","officialTitle":"A Randomized, Controlled, Double-Blind, Parallel-Group, Phase 3 Study to Compare the Pharmacokinetics, Efficacy and Safety Between CT-P10, Rituxan and MabThera in Patients With Rheumatoid Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-08","primaryCompletion":"2016-01","completion":"2017-01","firstPosted":"2014-05-29","resultsPosted":"2021-12-16","lastUpdate":"2021-12-16"},"enrollment":384,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"BIOLOGICAL","name":"CT-P10","otherNames":["rituximab"]},{"type":"DRUG","name":"Rituxan","otherNames":["rituximab"]},{"type":"DRUG","name":"MabThera","otherNames":["rituximab"]}],"arms":[{"label":"CT-P10","type":"EXPERIMENTAL"},{"label":"Rituxan","type":"ACTIVE_COMPARATOR"},{"label":"MabThera","type":"ACTIVE_COMPARATOR"}],"summary":"This is a Phase 3 Study to Compare the Pharmacokinetics, Efficacy and Safety between CT-P10, Rituxan and MabThera in Patients with Rheumatoid Arthritis.","primaryOutcome":{"measure":"Analysis of Serum AUC0-last of Rituximab During the 1st Course of the Main Study Period (Over the First 24 Weeks) (ANCOVA)","timeFrame":"over the first 24 weeks","effectByArm":[{"arm":"CT-P10 (Main Study Period)","deltaMin":162414.81,"sd":1.073},{"arm":"Rituxan (Main Study Period)","deltaMin":167309.07,"sd":1.073},{"arm":"MabThera (Main Study Period)","deltaMin":172450.97,"sd":1.075}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["31184752","30719632","30010481"],"seeAlso":["http://www.celltrion.com/"]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":161},"commonTop":["Upper respiratory tract infection","Infusion-related reaction","Urinary tract infection","Lower respiratory tract infection","Headache"]}}